¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ABBOTT HEPARIN SODIUM INJ. 10000IU"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® sodium ÇÑ±Û ³ªÆ®·ý
¼³¸í   
  ¿øÀÚ¹øÈ£ 11ÀÇ ±Ý¼Ó¿øÀÚ. ¼¼Æ÷ ¿Ü¾×ÀÇ °¡Àå ÈçÇÑ ¾çÀÌ¿ÂÀ¸·Î¼­ ¼¼Æ÷ ¿Ü¾×ÀÇ »ïÅõ¾Ð°áÁ¤¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» ÇÔ. ¾Ëµµ½ºÅ×·Ð(aldosterone: ÄáÆÏÀ§¿¡ Àִ ºÎ½Å¿¡¼­ ºÐºñÇÑ´Ù. Ç÷¾×³»ÀÇ »ïÅõ¾ÐÀ¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù)¿¡ ÀÇÇØ ÄáÆÏ¿¡¼­ ÀçÈí¼ö°¡ ÃËÁøµÇ¸ç Ã¼³» ¼öºÐ·®À» °áÁ¤Çϴ °¡Àå Áß¿äÇÑ ÀÎÀÚ. ½Å°æ¼¼Æ÷ µîÀÇ ÈïºÐ¼º ¼¼Æ÷ÀÇ ÈïºÐ½Ã ¼¼Æ÷³»·Î À¯ÀԵǾî ÈïºÐÀ» À¯¹ßÇϴ Áß¿äÇÑ ±â´Éµµ °¡Áø´Ù.
¿µ¹® heparin ÇÑ±Û ÇìÆÄ¸°
¼³¸í   
  Ç÷¾× ÀÀ°í¸¦ ¸·´Â ÀÛ¿ëÀ» Çϴ ´Ù´ç·ùÀǠȲ»ê¿¡½ºÅ׸£. °íµîµ¿¹°ÀÇ °¢Á¾ Á¶Á÷¿¡ ³Î¸® ºÐÆ÷µÇ¾î ÀÖÀ¸¸ç, ¼ö¼ú ÈÄÀÇ Ç÷ÀüÁõÀ» ¸·´Â µ¥ ¾´´Ù. Ç÷¾×ÀÀ°í¶õ ÁöÇ÷ÀÇ ÇÑ °úÁ¤À¸·Î ¼¶À¯¼Ò¶õ ¹°ÁúÀ» ¸¸µé¾î ³»´Â °úÁ¤ÀÌ´Ù. ÀÌ ¼¶À¯¼Ò´Â ¼Õ»óµÈ Ç÷°üÀÇ ºÎÀ§¿¡ ÀÛ¿ëÇÏ¿© ¿©·¯ °¡Áö ¼¼Æ÷µéÀ» ¾ô¾î ¹­´Â ¿ªÇÒÀ» ÇÏ¿© °á±¹ ¼Õ»óµÈ Ç÷°ü¿¡¼­ Ç÷¾×ÀÇ ¼Ò½ÇÀ» ¸·´Â´Ù. ÀÌ ¼¶À¯¼Ò´Â Æ®·Òºó¿¡ ÀÇÇØ ¼¶À¯¼Ò¿ø¿¡¼­ ÀüȯµÈ´Ù. ÇìÆÄ¸°À̶ó´Â ¹°ÁúÀº ÀÌ Æ®·ÒºóÀ» ¾ïÁ¦Çϴ Çׯ®·ÒºóÀ» È°¼ºÈ­Çϴ ¹°ÁúÀÌ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • Miller-Abbott tube
    ¹Ð·¯-¾Öº¸Æ®°ü
  • exchangeable sodium
    ±³È¯°¡´É³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
  • sodium bicarbonate
    Áßź»ê¿°³ªÆ®·ý
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium iodide
    ¿ä¿ÀµåÈ­³ªÆ®·ý
  • sodium pump
    ³ªÆ®·ýÆßÇÁ
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • sodium bicarbonate
    Áßź»ê¿°³ªÆ®·ý
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý°¨½Ã
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º°Ë»ç
  • sodium channel
    ³ªÆ®·ýÅë·Î
  • sodium chloride
    ¿°È­³ªÆ®·ý
  • exchangeable sodium
    ±³È¯³ªÆ®·ý
  • sodium iodide
    ¿ä¿ÀµåÈ­³ªÆ®·ý
  • sodium-potassium pump
    ³ªÆ®·ýÄ®·ýÆßÇÁ
  • sodium
    ³ªÆ®·ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fractional sodium excretion
    ºÐȹ¼º³ªÆ®·ý¹è¼³
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ»³ªÆ®·ý.
  • phethenylate sodium
    ÆäÅ×´Ò·¹ÀÌÆ®³ªÆ®·ý.
  • heparin
    ÇìÆÄ¸°
  • heparin cofactor II
    ÇìÆÄ¸°º¸Á¶ÀÎÀÚ II
  • heparin complement
    ÇìÆÄ¸°º¸Ã¼.
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(¡­Ò±àõãËúÐ).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(?ËÀËÛËàÌ´).
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º½ÃÇè.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • heparin cofactor II
    ÇìÆÄ¸°º¸Á¶ÀÎÀÚ II
  • heparin complement
    ÇìÆÄ¸°º¸Ã¼.
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(?ËÀËÛËàÌ´).
  • heparin protamin tolerance test
    ÇìÆÄ¸° ÇÁ·ÎŸ¹Î ³»¼º½ÃÇè(¡­Ò±àõãËúÐ).
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • heparin tolerance test
    ÇìÆÄ¸°³»¼º½ÃÇè.
  • thrombocytopenia induced by heparin
    ÇìÆÄ¸°À¯Àμº Ç÷¼ÒÆÇ°¨¼ÒÁõ
  • calcium sodium exchange
    Ä®½·-³ªÆ®·ý ±³È¯(-Îßüµ)
  • exchangeable sodium
    ±³È¯¼º ³ªÆ®·ý
  • exsiccated sodium arsenate<³ª> sodii ar se nas exsiccatus
    °ÇÁ¶ºñ»ê³ªÆ® ·ý.
  • exsiccated sodium phosphate
    °ÇÁ¶Àλê(¡­ìÝß«)³ªÆ®·ý.
  • fluorescein sodium
    Ç÷οÀ·¹½Å ³ªÆ®·ý.
  • fractional sodium excretion
    ºÐȹ¼º³ªÆ®·ý¹è¼³
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ»³ªÆ®·ý.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sodium antimony gluconate
    ¾ÈƼ¸ó±Û·çÄڻ곪Ʈ·ý
  • sodium stibogluconate
    ±Û·çÄڻ곪Ʈ·ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • sodium azide
    ¾ÆÁöµåÈ­(ûù) ³ªÆ®¸®¿ò
  • sodium dodecyl sulfate
    µµµ¥½ÇȲ»ê(üÜß«) ³ªÆ®¸®¿ò
  • sodium dodecyl sulfate polyacrylamide gel electrophoresis
    µµµ¥½Ç Ȳ»ê(üÜß«) ³ªÆ®¸®¿ò Æú¸®¾ÆÅ©¸±¾Æ¸¶À̵å Àü±â¿µµ¿(ï³Ñ¨ç¶ÔÑ)
  • sodium error
    ¼Òµð¿ò ¿ÀÂ÷(è¦ó¬)
  • sodium lauryl sulfate
    ¶ó¿ì¸± Ȳ»ê ³ªÆ®¸®¿ò
  • sodium pentobarbital
    ÆæÅä¹Ù¸£ºñÅ» ³ªÆ®¸®¿ò
  • sodium pump
    ¼Òµð¿ò ÆßÇÁ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°
  • sodium
    ³ªÆ®·ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
inj injection; injury, injured, injurious
M-A tube Miller Abbott tube
MA malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern...
DOSS distal over-shoulder strap; dioctyl sodium sulfosuccinate; docusate sodium
DSS dengue shock syndrome; dioctyl sodium sulfosuccinate; Disability Status Scale; discrete subaortic st...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LMW heparin Low Molecular Weight heparin
HEP 1--heparin
HSPG heparin sulfate proteoglycan
H Heparin
HE Heparin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Abbott-Miller tube
    ¾Æº¸Æ®-¹Ð·¯ °ü
    Àå Æó»öÁõÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â °ü.
  • heparin sulfate
    ÇìÆÄ¸° ¼³ÆäÀÌÆ®
    Ȳ»ê ÇìÆÄ¸®Æ¾.
  • aldosterone-mediated sodium
    ¾Ëµµ½ºÅ×·Ð Áß°³µÈ ³ªÆ®·ý
  • barbital sodium
    ¹Ù¸£ºñÅ» ³ªÆ®·ý
  • butabarbital sodium
    ºÎŸ¹Ù¸£ºñÅ» ³ªÆ®·ý
    ÁøÁ¤ ¹× ¼ö¸éÁ¦·Î »ç¿ëÇÏ°í °æ±¸ÀûÀ¸·Î Åõ¿©ÇÑ´Ù.
  • dextrothyroxine sodium
    µ¦½ºÆ®·ÎŸÀ̷ϽгªÆ®·ý
    thyroxineÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ ³ªÆ®·ý ¿°. ´ãȲ»öÀÇ ºÐ¸». °úÄÝ·¹½ºÅ×·ÑÇ÷ÁõÀÇ Ä¡·á¿¡ »ç¿ëÇÑ´Ù.
  • exchangeable sodium
    ±³È¯¼º ³ªÆ®·ý
  • exsiccated sodium phosphate
    °ÇÁ¶ ÀÎ»ê ³ªÆ®·ý
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • hexobarbital sodium
    Çí»ç¹Ù¸£ºñÅ» ³ªÆ®·ý
  • meralluride sodium
    ¸Þ¶ö·ç¶óÀÌµå ³ªÆ®·ý
  • morrhuate sodium : °£À¯ÀÇ Áö¹æ»ê ³ªÆ®·ý¿°. °æÈ­Á¦·Î¼­ ƯÈ÷ Á¤¸Æ·ù ¹× Ä¡ÁúÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç Á¤¸Æ·ù ³»·Î ¿ë¾×À» ÁÖ»çÇÑ´Ù.

    morrhuic acid

    ¸ð·çÀλê
  • naproxen sodium

    naprylate (³ªÇÁ¸±·¹ÀÌÆ®

    ÇǺΠÁø±ÕÁõÀÇ Ä¡·áÁ¦.
  • serum sodium
    Ç÷û ³ªÆ®·ý
  • sodium
    ³ªÆ®·ý
    ¹é»öÀÇ ¾ËÄ®¸®¼º ±Ý¼Ó ¿ø¼Ò, Na, ¿øÀÚ ¹øÈ£ 11, ¿øÀÚ·® 22.990, ºñÁß 0.971, ¿øÀÚ°¡ 1.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
Abbott, Alexander <person> U.S. Bacteriologist, 1860-1935.
See: Abbott's stain for spores.
(05 Mar 2000)
Abbott, Edville <person> U.S. Orthopedic surgeon, 1871-1938.
See: Abbott's method.
(05 Mar 2000)
Abbott's artery <anatomy, artery> An anomalous artery arising from the posteromedial proximal descending aorta, important during coarctation repair.
(05 Mar 2000)
Abbott's method A method of treatment of scoliosis by use of a series of plaster jackets applied after partial correction of the curvature by external force.
(05 Mar 2000)
Abbott's stain <technique> Spores are stained blue with alkaline methylene blue; bodies of the bacilli become pink with eosin counterstain.
(05 Mar 2000)
Abbott's tube A tube with two lumens, one ending in a small collapsible balloon and the other in a metallic tip with numerous perforations; used for intestinal decompression.
Synonym: Abbott's tube.
(05 Mar 2000)
Abbott, W. Osler <person> U.S. Physician, 1902-1943.
See: Abbott's tube, Miller-Abbott tube.
(05 Mar 2000)
Miller-Abbott tube A tube with two lumens, one ending in a small collapsible balloon and the other in a metallic tip with numerous perforations; used for intestinal decompression.
Synonym: Abbott's tube.
(05 Mar 2000)
heparin <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin.
(18 Nov 1997)
heparin antagonists Coagulant substances inhibiting the anticoagulant action of heparin.
(12 Dec 1998)
heparin binding growth factor <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells.
Synonym: heparin binding growth factor.
Acronym: FGF
(18 Nov 1997)
heparin cofactor II <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily.
Pharmacological action: serine proteinase inhibitors.
Chemical name: Heparin cofactor II
(12 Dec 1998)
heparin complement The protein component of heparin in blood.
(05 Mar 2000)
heparin eliminase <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends.
Chemical name: heparin lyase
Registry number: EC 4.2.2.7
(12 Dec 1998)
heparin-glucosamine 3-O-sulfotransferase <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate
Registry number: EC 2.8.2.23
Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase
(26 Jun 1999)
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 1 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¾Öº¸Æ®ÇìÆÄ¸°³ªÆ®·ýÁÖ10000´ÜÀ§ - »õâ
Abbott
W01860131 Heparin sodium
Àü¹®ÀǾàǰ | »èÁ¦
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • heparin
    ÇìÆÄ¸°;(°£ÀåÀ̳ª ÆóÀÇ Ç÷¾× ÀÀ°í¸¦ ¸·´Â ¹°Áú)
  • sodium
    ³ªÆ®·ý
  • cormolyn sodium
    Å©·Î¸ô¸° ³ªÆ®·ý(±â°üÁö È®ÀåÁ¦)
  • pentobarbital sodium
    ÆæÅä¹Ù¸£ºñÅ» ³ªÆ®·ý(´Ü½Ã°£Çü ÁøÁ¤,ÃÖ¸é,ÁøÅë¾à)
  • sodium
    ³ªÆ®·ý(±Ý¼Ó ¿ø¼Ò,±âÈ£ Na)
  • sodium bicarbonate
    Áßź»ê³ªÆ®·ý 
  • sodium chloride
    ¿°È­³ªÆ®·ý;¼Ò±Ý
  • sodium fluoride
    ºÒÈ­³ªÆ®·ý(¼Òµ¶,¹æºÎÁ¦)
  • sodium hydroxide
    ¼ö»êÈ­ ³ªÆ®·ý 
  • sodium nitrate
    Áú»ê³ªÆ®·ý
  • sodium pentothal
    ÆæÅäÅ»³ªÆ®·ý(¸¶Ãë,ÃÖ¸é¾à¿ë)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á